MYELODYSPLASTIC SYNDROME (Disease Or Phenotype)

Omim:614286

Nci:C3247

Msh:D009190

Mondo:MONDO:18881

Medcin:MEDCIN:35938

Mdr:MDR:10028532

Id:d260781b-94ce-5ec8-b816-a8a5b8eb1d8c

Icpc2icd10eng:MTHU050847

Icd10cm:D46

Efo:EFO:198

Doid:DOID:50908

Chv:CHV:8407

Linked to

	Label	Description
	Lenalidomide indication MYELODYSPLASTIC SYNDROME Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	Decitabine indication MYELODYSPLASTIC SYNDROME Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	(4R)-2'-Deoxy-2'2'-difluoro-3,4,5,6-tetrahydrouridine indication MYELODYSPLASTIC SYNDROME Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG
	5-Azacitidine indication MYELODYSPLASTIC SYNDROME Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from IDG

Lenalidomide indication MYELODYSPLASTIC SYNDROME

A Knowledge Graph Assertion from IDG

Decitabine indication MYELODYSPLASTIC SYNDROME

A Knowledge Graph Assertion from IDG

(4R)-2'-Deoxy-2'2'-difluoro-3,4,5,6-tetrahydrouridine indication MYELODYSPLASTIC SYNDROME

A Knowledge Graph Assertion from IDG

5-Azacitidine indication MYELODYSPLASTIC SYNDROME

A Knowledge Graph Assertion from IDG

DISPLAY PER PAGE

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025